We conducted a multicenter randomized double-blind clinical trial among 626 men with mild to moderate hypertension to determine the effects of captopril, methyldopa, and propranolol on their quality of life. Hydrochlorothiazide was added if needed to control blood pressure. After a 24-week treatment period, all three groups had similar blood-pressure control, although fewer patients taking propranolol required hydrochlorothiazide. Patients taking captopril alone or in combination with a diuretic were least likely to withdraw from treatment because of adverse effects (8 percent vs. 20 percent for methyldopa and 13 percent for propranolol). The treatment groups were similar in scores for sleep dysfunction, visual memory, and social participation. However, patients taking captopril, as compared with patients taking methyldopa, scored significantly higher (P less than 0.05 to less than 0.01) on measures of general well-being, had fewer side effects, and had better scores for work performance, visual-motor functioning, and measures of life satisfaction. Patients taking propranolol also reported better work performance than patients taking methyldopa. Patients taking captopril reported fewer side effects and less sexual dysfunction than those taking propranolol and had greater improvement (P less than 0.05 to less than 0.01) on measures of general well-being. Our findings show that antihypertensive agents have different effects on the quality of life and that these can be meaningfully assessed with available psychosocial measures.
This article has been cited by other articles:
Jennings, J. R., Muldoon, M. F., Whyte, E. M., Scanlon, J., Price, J., Meltzer, C. C.
(2008). Brain Imaging Findings Predict Blood Pressure Response to Pharmacological Treatment. Hypertension
52: 1113-1119
[Abstract][Full Text]
Henkin, R. I.
(2008). Taste and Appetite Loss in the Aged. Gerontology
13: 20-32
[Abstract][Full Text]
Jennings, J. R., Muldoon, M. F., Price, J., Christie, I. C., Meltzer, C. C.
(2008). Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment. Hypertension
52: 65-71
[Abstract][Full Text]
Testa, M. A., Simonson, D. C.
(2007). Satisfaction and Quality of Life With Premeal Inhaled Versus Injected Insulin in Adolescents and Adults With Type 1 Diabetes. Diabetes Care
30: 1399-1405
[Abstract][Full Text]
Sarkar, U., Ali, S., Whooley, M. A.
(2007). Self-Efficacy and Health Status in Patients With Coronary Heart Disease: Findings From the Heart and Soul Study. Psychosom. Med.
69: 306-312
[Abstract][Full Text]
Kennedy, D. J., Burket, M. W., Khuder, S. A., Shapiro, J. I., Topp, R. V., Cooper, C. J.
(2006). Quality of life improves after renal artery stenting.. Biol Res Nurs
8: 129-137
[Abstract]
Schwarz, E. R., Rastogi, S., Kapur, V., Sulemanjee, N., Rodriguez, J. J.
(2006). Erectile Dysfunction in Heart Failure Patients. J Am Coll Cardiol
48: 1111-1119
[Abstract][Full Text]
Abrams, H. B., Chisolm, T. H., McArdle, R.
(2005). Health-Related Quality of Life and Hearing Aids: A Tutorial. TRENDS AMPLIF
9: 99-109
[Abstract]
Ho, N. C., Bunch, T. J., White, R. D., Packer, D. L.
(2003). Long-Term Outcomes after Successful Early Defibrillation. NEJM
349: 1777-1777
[Full Text]
Ruo, B., Rumsfeld, J. S., Hlatky, M. A., Liu, H., Browner, W. S., Whooley, M. A.
(2003). Depressive Symptoms and Health-Related Quality of Life: The Heart and Soul Study. JAMA
290: 215-221
[Abstract][Full Text]
Reddy, B. K., Kennedy, D. J., Colyer, W. R., Burket, M. W., Thomas, W. J., Khuder, S. A., Shapiro, J. I., Topp, R. V., Cooper, C. J.
(2003). Compliance with Antihypertensive Therapy after Renal Artery Stenting. Biol Res Nurs
5: 37-46
[Abstract]
Gupta, K., Gupta, S., Cohen, J. D.
(2002). Undertreatment of Hypertension: A Dozen Reasons. Arch Intern Med
162: 2246-2248
[Full Text]
Hlatky, M. A., Boothroyd, D., Vittinghoff, E., Sharp, P., Whooley, M. A., for the HERS Research Group,
(2002). Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy: Results From the Heart and Estrogen/Progestin Replacement Study (HERS) Trial. JAMA
287: 591-597
[Abstract][Full Text]
Niskanen, L., Hedner, T., Hansson, L., Lanke, J., Niklason, A.
(2001). Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/{beta}-Blocker-Based Treatment Regimen: A subanalysis of the Captopril Prevention Project. Diabetes Care
24: 2091-2096
[Abstract][Full Text]
Mulrow, C. D, Pignone, M.
(2001). Evidence based management of hypertension: What are the elements of good treatment for hypertension?. BMJ
322: 1107-1109
[Full Text]
Biglioli, P., Antona, C., Alamanni, F., Parolari, A., Toscano, T., Pompilio, G., Polvani, G.
(2000). Minimally invasive direct coronary artery bypass grafting: midterm results and quality of life. Ann. Thorac. Surg.
70: 456-460
[Abstract][Full Text]
Hollenberg, N. K., Williams, G. H., Anderson, R.
(2000). Medical Therapy, Symptoms, and the Distress They Cause: Relation to Quality of Life in Patients With Angina Pectoris and/or Hypertension. Arch Intern Med
160: 1477-1483
[Abstract][Full Text]
Cheng, J. D., Hitt, J., Koczwara, B., Schulman, K. A., Burnett, C. B., Gaskin, D. J., Rowland, J. H., Meropol, N. J.
(2000). Impact of Quality of Life on Patient Expectations Regarding Phase I Clinical Trials. JCO
18: 421-421
[Abstract][Full Text]
Anderson, R. B., Hollenberg, N. K., Williams, G. H.
(1999). Physical Symptoms Distress Index: A Sensitive Tool to Evaluate the Impact of Pharmacological Agents on Quality of Life. Arch Intern Med
159: 693-700
[Abstract][Full Text]
Testa, M. A., Simonson, D. C.
(1998). Health Economic Benefits and Quality of Life During Improved Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled, Double-Blind Trial. JAMA
280: 1490-1496
[Abstract][Full Text]
Rummans, T. A., Frost, M., Suman, V. J., Taylor, M., Novotny, P., Gendron, T., Johnson, R., Hartmann, L., Dose, A. M., Evans, R. W.
(1998). Quality of Life and Pain in Patients With Recurrent Breast and Gynecologic Cancer. Psychosomatics
39: 437-445
[Abstract][Full Text]
Pae, W. E. Jr, Anderson, J. M., Blackstone, E. H., Boroevetz, H. S., Ciarkowski, A., Copeland, J. G. III, Costanzo-Nordin, M. R., Daase, K., Dew, M. A., Domanski, M. J., Eidleman, B. H., Evans, R. W., Farrar, D. J., Frazier, O.H., Griffith, B. P., Hahn, C.-J., Hill, J. D., Hunt, S., Kendell, K., Kormos, R. L., Levin, H. R., Mancini, D. M., McCarthy, P. M., McNamara, D., O'Rourke, F. K., Parker, L., Pennington, D. G., Poirier, V. L., Portner, P. M., Rose, E. A., Sapirstein, W., Schron, E., Shanker, R., Subramanian, R., Wallwork, J., Stevenson, L. W., Pennington, D. G., Copeland, J. G. III, Frazier, O. H., Griffith, B. P., Hahn, C.-J., Hill, J. D., Kaiser, L. R., Magovern, G. J., Pae, W. E. Jr, Rose, E. A.
(1998). Bethesda conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure. Ann. Thorac. Surg.
66: 1452-1465
[Full Text]
Svardh, C., Isacson, D., Pedersen, N. L.
(1998). Self-rated health among cardiovascular drug users in a study of Swedish twins. Scand J Public Health
26: 223-231
[Abstract]
Bulpitt, C J, Fletcher, A E, Dössegger, L, Neiss, A, Nielsen, T, Viergutz, S
(1998). Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Heart
79: 593-598
[Abstract][Full Text]
Grimm, R. H. Jr, Grandits, G. A., Prineas, R. J., McDonald, R. H., Lewis, C. E., Flack, J. M., Yunis, C., Svendsen, K., Liebson, P. R., Elmer, P. J., Stamler, J.
(1997). Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS). Hypertension
29: 8-14
[Abstract][Full Text]
Fahey, T P, Peters, T J
(1996). What constitutes controlled hypertension? Patient based comparison of hypertension guidelines. BMJ
313: 93-96
[Abstract][Full Text]
Testa, M. A., Simonson, D. C.
(1996). Assessment of Quality-of-Life Outcomes. NEJM
334: 835-840
[Full Text]
Hays, R. D., Cunningham, W. E., Ettl, M. K., Beck, C. K., Shapiro, M. F.
(1995). Health Related Quality of Life in HIV Disease. Assessment
2: 363-380
[Abstract]
Jones, J K, Gorkin, L, Lian, J F, Staffa, J A, Fletcher, A P
(1995). Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ
311: 293-295
[Abstract][Full Text]
Piette, J., Wachtel, T. J., Mor, V., Mayer, K.
(1995). The Impact of Age on the Quality of Life in Persons with HIV Infection. J Aging Health
7: 163-178
[Abstract]
Monane, M., Glynn, R. J., Gurwitz, J. H., Bohn, R. L., Levin, R., Avorn, J.
(1995). Trends in Medication Choices for Hypertension in the Elderly : The Decline of the Thiazides. Hypertension
25: 1045-1051
[Abstract][Full Text]
Ray, W. A., Griffin, M. R, Avorn, J.
(1993). Evaluating Drugs after Their Approval for Clinical Use. NEJM
329: 2029-2032
[Full Text]
Santanello, N. C., Guess, H., Heyse, J. F., Kaplan, N. M., Waud, D. R., Fletcher, A., Ware, J. E., Testa, M. A., Hollenberg, N. K.
(1993). Captopril, Enalapril, and Quality of Life. NEJM
329: 505-507
[Full Text]
Drummond, M. F., Heyse, J., Cook, J., McGuire, A.
(1993). Selection of End Points in Economic Evaluations of Coronary-heart-disease Interventions. Med Decis Making
13: 184-190
[Abstract]
Testa, M. A., Anderson, R. B., Nackley, J. F., Hollenberg, N. K., The Quality-of-Life Hypertension Study Group,
(1993). Quality of Life and Antihypertensive Therapy in Men -- A Comparison of Captopril with Enalapril. NEJM
328: 907-913
[Abstract][Full Text]
Oparil, S.
(1993). Antihypertensive Therapy -- Efficacy and Quality of Life. NEJM
328: 959-961
[Full Text]
Kobayashi, S., Yamaguchi, S., Okada, K., Suyama, N., Bokura, K., Murao, M.
(1992). The Effect of Enalapril Maleate on Cerebral Blood Flow in Chronic Cerebral Infarction. ANGIOLOGY
43: 378-388
[Abstract]
Saito, I., Takeshita, E., Hayashi, S., Takenaka, T., Murakami, M., Saruta, T., Nagano, S., Sekihara, T.
(1990). Effect of Captopril on Plasma Prolactin in Patients with Essential Hypertension. ANGIOLOGY
41: 377-381
[Abstract]
Munger, M. A., Gardner, S. F., Jarvis, R. C.
(1990). Endocrinologic Warfare: The Role of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure. Journal of Pharmacy Practice
3: 318-331
[Abstract]
German, P. S., Burton, L. C.
(1989). Medication and the Elderly: Issues of Prescription and Use. J Aging Health
1: 4-34
[Abstract]
Clark, T. T., Zbrozek, A. S., Rehder, T. L.
(1989). Health Economics Research: An Emerging Pharmacy Practice Discipline. Journal of Pharmacy Practice
2: 110-116
[Abstract]
Sabo, C. E., Michael, S. R.
(1989). Pharmacy Update: Drug Therapy for the Hypertensive Diabetic Patient: Implications for the Diabetes Educator. The Diabetes Educator
15: 377-385
Chobanian, A.
(1989). The Role of Angiotensin-Converting Enzyme Inhibitors in the Therapy of Cardiovascular Disease: An Overview. ANGIOLOGY
40: 331-334
Maclean, D.
(1989). Quinapril: A Double-Blind, Placebo-Controlled Trial in Essential Hypertension. ANGIOLOGY
40: 370-381
[Abstract]
Schechter, C. B., Adler, R. S.
(1988). Bayesian Analysis of Diastolic Blood Pressure Measurement. Med Decis Making
8: 182-190
[Abstract]
Lewis, R.V.
(1987). Quantifying Side-Effects of Beta-Blockers: The Role of Visual Analogue Scales. Hum Exp Toxicol
6: 195-201
[Abstract]
Previous
